SDF1-3'A polymorphism is associated with increased risk of hematological malignancy: a meta-analysis.
Ontology highlight
ABSTRACT: CXCL12 (also named SDF1), a member of the chemokine family, has been demonstrated to play an important role in the progression of multiple types of hematological malignancy. Several recent studies have shown that SDF1-3'A polymorphism (rs1801157) is associated with susceptibility to hematological malignancy, but published studies' results are disputed. Therefore, we performed a meta-analysis to evaluate the relationship between SDF1-3'A polymorphism and the risk of hematological malignancy based on the existing literature. We carried out a comprehensive literature search using the Web of Science, PubMed, Cochrane Library, Chinese Wan Fang, and Chinese National Knowledge Infrastructure databases. And the raw data were extracted and calculated in standard steps of
SUBMITTER: Zhang X
PROVIDER: S-EPMC5359121 | biostudies-literature | 2017
REPOSITORIES: biostudies-literature
ACCESS DATA